Fairscale Capital »

United Therapeutics Corporation shares owned by Fairscale Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Fairscale Capital from 13F filings

Historical chart of Fairscale Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Fairscale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Fairscale Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 50 419.22
2025-06-30 $14k 50 274.70
2025-03-31 $15k 50 308.28
2024-12-31 $18k 50 352.84
2024-09-30 $18k 50 358.36
2024-06-30 $16k 50 328.20

More positions owned by Fairscale Capital

Vanguard S&p 500 Etf idx (VOO)
NVIDIA Corporation (NVDA)
iShares S&P NA Tech. Sec. Idx (IGM)
Apple (AAPL)
Vanguard Admiral Fds Inc equity (VOOV)
Microsoft Corporation (MSFT)
Pacer Fds Tr us cash cows 100 (COWZ)
Invesco Qqq Trust Series 1 (QQQ)
Alphabet Inc Class A cs (GOOGL)
Visa (V)
Amazon (AMZN)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Facebook Inc cl a (META)
Schwab Strategic Tr us dividend eq (SCHD)

View all positions for Fairscale Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation